Study shows potential cost savings for early detection and treatment of type 2 diabetes

April 17, 2018, Aarhus University

Health checks, including diabetes risk assessment, have been introduced in a number of countries. However, there are few population-based trials assessing the benefits, harms and costs of these screening programmes, and these have shown mixed results.

Between 2001 and 2006, a population-based cardiovascular and diabetes programme was introduced in five out of 16 Danish counties. Over 150,000 registered with 181 practices participating in the ADDITION-Denmark study were sent a diabetes risk score questionnaire, and if their score indicated moderate to high risk, willing participants received a diabetes test and cardiovascular risk assessment with their family doctor.

More than 27,000 attended the screening, and 1533 were diagnosed with diabetes during screening. A further 1,760,000 individuals were identified for a matched no-screening control group. Participants were followed for approximately six years following diagnosis until 31 December 2012, when national registers were searched for healthcare usage and healthcare cost.

The researchers found that those individuals with clinically diagnosed diabetes were identified on average 2.2 years later than individuals whose diabetes was detected in the screening practices. Healthcare costs were significantly lower in the screening group compared with the no-screening control group, with an average annual difference in healthcare costs of €889 per individual with diabetes. The results have just been published in the scientific journal Diabetologia.

Lead author Camilla Sortsø says, "While trials of population-based screening for type 2 diabetes have not demonstrated beneficial effects at the population level, we have previously shown that there are benefits for those found to have diabetes. This study contributes to our previous research by showing that and treatment among individuals at of type 2 diabetes has the potential to reduce costs."

The published results are based on the Danish part of the ADDITION study. The ADDITION study is a Danish initiated, international study with partners in Cambridge, U.K., and Utrecht, Holland.

The began in 2000 with the participation of from 181 practices in Denmark. All of the general practitioners were trained in systematic early detection of diabetes. The majority of the general practitioners sent a risk questionnaire to all patients aged 40 to 69, while a smaller group of general practitioners handed out the questionnaire to their patients or handed it out when patients visited the doctor for reasons other than diabetes.

In addition, half of the doctors were trained to give intensive treatment consisting of lifestyle changes (healthy diet, exercise, smoking stop) and preventive medicine to lower blood sugar levels, blood pressure and cholesterol in the blood. The other half of the general practitioners treated patients in accordance with the existing treatment guidelines.

The randomised study showed a 17 percent decrease in cardiovascular disease after five years, a relevant but not statistically significant difference. Morbidity and mortality in the group that was treated in accordance with the existing treatment guidelines proved to be considerably lower than among patients who were given the diabetes diagnosis without systematic screening.

Torsten Lauritzen, Aarhus University and guarantor for the present study tells: "The present paper is based on a recent publication in Diabetologia (2017) demonstrating that a single round of diabetes screening and cardiovascular risk assessment was associated with a 16 percent risk reduction in cardiovascular disease and a 21 percent reduction in all-cause mortality in individuals diagnosed with between 2001 and 2009."

Explore further: Effect of population screening for type 2 diabetes

More information: Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009, www.springermedizin.de/effect- … 04?fulltextView=true

Related Stories

Effect of population screening for type 2 diabetes

August 24, 2017
Three large trials published today in Diabetologia (the journal of the European Association for the Study of Diabetes) show that screening for type 2 diabetes and cardiovascular risk factors may not reduce mortality and cardiovascular ...

Genetic signature predicts diabetes diagnosis

April 9, 2018
University of Queensland researchers have found a way to identify infants who will go on to develop type 1 diabetes.

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes screening study finds no reduction in mortality rates

October 3, 2012
The randomised trial, which is the first ever study evaluating the effect of type 2 diabetes screening programmes on overall mortality rates in a population, assessed the number of deaths over ten years in a group of more ...

Intensive BP goals reduce risk of cardiovascular events

December 19, 2017
(HealthDay)—Intensive blood pressure lowering may similarly decrease cardiovascular events in both patients with and patients without type 2 diabetes mellitus, according to a study published online Dec. 6 in Diabetes Care.

Interventions increase attendance for diabetic retinopathy screening, says study

January 31, 2018
Targeted interventions can significantly improve screening for diabetic retinopathy, a complication of diabetes and the leading cause of vision loss amongst working-age adults in the Western word, according to a new Cochrane ...

Recommended for you

New therapeutic avenue for type 2 diabetes

December 6, 2018
Restoring the action of insulin is one of the keys to fighting type 2 diabetes. Researchers from Inserm led by Dominique Langin at the Institute of Cardiovascular and Metabolic Diseases (Inserm/Université de Toulouse) are ...

Subtype of immune B cells can delay type 1 diabetes onset in mice

December 6, 2018
A team of researchers at Baylor College of Medicine and the University of Michigan Medical School reports today in the JCI Insight that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 ...

Is the pancreas regeneration debate settled? An original theory renewed

December 5, 2018
A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

One in four patients say they've skimped on insulin because of high cost

December 3, 2018
For patients with diabetes, insulin is a life-saving medicine and an essential component of diabetes management, yet in the past decade alone, the out-of-pocket costs for insulin have doubled in the United States. One-quarter ...

Parsing diabetic skin infections

December 3, 2018
People with diabetes are more susceptible to skin infection. According to a new study by C. Henrique Serezani, Ph.D., Stephanie Brandt, Ph.D., and colleagues, this susceptibility might be due to overabundance of a compound ...

Next step toward replacement therapy in type 1 diabetes

November 28, 2018
Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they are very mobile and that their destiny is strongly influenced by their immediate environment. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.